KAT5 and ovarian carcinoma: In addition, Xiao et al.’s study of ovarian cancer found that aspirin inhibited the expression of PD-L1 by inhibiting KAT5, thereby inhibiting the signaling pathway of PD-1 and PD-L1 to attenuate the progression of ovarian cancer15.